VANI — Vivani Medical, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1266806 ·
Last close
$1.24
Market Cap
$106.93M
52W High
$1.53
52W Low
$0.92
ADV30
298,312
Next earnings
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -6,817,000 -6,780,000 42,353,000 19,749,000 23,268,000
Dec 2025 0 -6,810,000 -6,633,000 39,393,000 16,232,000 23,663,000
Sep 2025 0 -6,725,000 -6,530,000 25,046,000 2,628,000 23,737,000
Jun 2025 0 -7,462,000 -7,144,000 28,905,000 6,794,000 23,995,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-24,320,000
Investing CF
$-1,173,000
Financing CF
$23,274,000
CapEx
$-1,173,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.45
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-148,533,000
Inventory
Receivables
$654,000
ST Investments
EBIT TTM
$-27,554,000
Pretax Income TTM
$-26,609,000
Interest Exp TTM
Analysts
3

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -27,556,000 -26,609,000 39,393,000 23,663,000 -24,320,000
Dec 2024 0 -24,677,000 -23,486,000 41,561,000 23,951,000 -20,786,000
Dec 2023 0 -26,965,000 -25,652,000 45,797,000 25,036,000 -23,699,000
Dec 2022 0 -21,241,000 -13,889,000 51,130,000 6,822,000 -18,787,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.35

Peers — same industry

TickerNameMarket CapLastDaily %
LAKE LAKELAND INDUSTRIES INC $104.98M $10.65
SKIN SkinHealth Systems Inc. $111.24M $0.86
AVHHL AVITA Medical, Inc. $111.57M $0.73
FONR FONAR CORP $116.65M $18.91
NYXH Nyxoah SA $120.67M $2.70

News headlines (Yahoo Finance, 1h cache)

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation
2026-05-15 11:21 · Yahoo
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-13 20:05 · Yahoo
Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?
2026-04-03 16:00 · Yahoo
Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright
2026-04-01 15:51 · Yahoo
Vivani Medical: Q4 Earnings Snapshot
2026-03-26 20:45 · Yahoo
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2026-03-26 20:16 · Yahoo
Insiders Are Still Scooping Up Under Armour and WR Berkley Shares
2026-01-31 13:15 · Yahoo
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
2026-01-29 12:30 · Yahoo
Vivani Medical, Inc. Announces Closing of Common Stock Offering
2026-01-27 21:05 · Yahoo
GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window
2026-01-27 13:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.